References
- Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004;137(2):337–42
- Wilson SE. Inflammation:a unifying theory for the origin of dry eye. Managed Care 2003;12(Suppl):14–19
- Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol 2004;15(4):299–304
- Perry HD, Donnenfeld ED, Perry AR, et al. Evaluation of topical cyclosporine A 0.05% for the treatment of dry eye disease. Presented in part as a paper at the 2004 American Academy of Ophthalmology Annual Meeting, New Orleans, Louisiana, USA
- Schein OD, Tielsch JM, Munoz B, et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997;104:1395–401
- Schaumberg DA, Sullivan DA, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318–26
- Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003;44:4753–61
- O’Brien PD, Collum LMT. Dry eye:diagnosis and current treatment strategies. Curr Allergy Asthma Rep 2004;4:314–9
- Perry HD, Donnefeld ED. Topical 0.05% cyclosporin A in the treatment of dry eye. Expert Opin Pharmacother 2004;5(10):2099–107
- Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease [CsA Phase 3 Study Group]. Ophthalmology 2000;107:631–9
- Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease:a dose-ranging randomized trial [The Cyclosporin A Phase 2 Study Group]. Ophthalmology 2000;107: 967–74
- Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004;23:272–85
- Turner K, Pflugfelder SC, et al. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 2000;19:492–6
- Tauber J. A dose-ranging clinical trial to assess the safety and efficacy of cyclosporine ophthalmic emulsion in patients with keratoconjunctivitis sicca [The Cyclosporine Study Group]. Adv Exp Med Biol 1998;438:969–72